GlaxoSmithKline stave off shareholder rebellion

Bosses of drugs company GlaxoSmithKline headed off a rebellion over the company’s executive pay packages today.

Glaxo chairman Christopher Hogg said that although final figures were unavailable, at least 85% of votes cast were in favour of the company’s remuneration report, while votes cast on all other resolutions exceed 95%.